Here is a look at some of the treatment alternatives, which can offer simpler logistics and cost considerations.
A new study demonstrated that gut organisms can alter drug availability by biotransformation on a significantly broader scale than previously expected.
Gender-affirming hormone therapy (GAHT) therapy consists of administration of exogenous hormones and suppression of endogenous hormone production, with the goal of obtaining characteristics more congruent with an individual’s gender identity. Here is a review of these therapies and consideration for PrEP and the risks associated with HIV in this diverse population.
The broad host range and natural reassortment of the influenza virus has played an instrumental role in previous pandemics, and the virus is poised for future large-scale outbreaks.
With evolving weather patterns, the natural habitat of ticks is expanding, and more people are becoming susceptible to them.
Gonococcal septic polyarthritis is an uncommon manifestation of N gonorrhoeae infection, but has increased by about 40% in recent years.
Emerging literature suggests therapeutic drug monitoring for this antimicrobial to minimize the risk for linezolid-associated toxicities while maintaining efficacy in select populations.
Key opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.
Although fecal microbiota, live-jslm (Rebyota; RBX2660) is the first fecal microbiota product approved by the FDA, there are other microbiota-based agents in the pipeline.
Key opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.
A rare case of Pott puffy tumor occurs in an atypical patient with no risk factors, likely due to untreated sinus infection.
Guest author Seth Lederman, MD, calls Long COVID "one of the most pressing global health threats I have seen since fighting HIV/AIDS."
Gonococcal septic polyarthritis is an uncommon manifestation of N gonorrhoeae infection, but has increased by about 40% in recent years.
Although this patient had none of these common risk factors associated with Candida empyema, she did have other factors predisposing her to fungal colonization and subsequent infection.
Findings increasingly suggest the mortality risk may be reduced by initiating daptomycin within 3 days of infection.
Tina Tan, MD; Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Priya Nori, MD; Jacinda Abdul-Mutakabbir, PharmD; and Kevin Michael Reiter, MD, PA, provide key takeaways from the discussion on the treatment of respiratory viral infections.
Demystifying clinical data for treating invasive AmpC-harboring Enterobacterales.
A food for thought as an ambulatory antibiotic stewardship initiative.
This novel therapeutic option represents the first long-acting injectable approved for maintenance of HIV-1 suppression.
Will there be an answer to keep the continuously evolving virus at bay? Are seasonal combination vaccines the wave of the future?
Closing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.
The Centers for Disease Control and Prevention (CDC) reports the rise in pediatric acute respiratory illnesses especially as there is a decrease in hygiene measures that were previously employed during the pandemic.
Findings increasingly suggest the mortality risk may be reduced by initiating daptomycin within 3 days of infection.
Examining pharmacological management in COVID-19 patients with ARDS requiring antifungal therapy during extracorporeal life support.
A pair of experts assess literature on the means of interpreting hospitalized patient antibiotic resistance through machine learning.
Clinicians look at optimal approaches for trying to avoid Clostridioides difficile infection (CDI).
The latest article from SIDP offers a Top 5 list of how to precept a learner on an infectious disease rotation.
There is limited and conflicting data regarding the role of combination antifungal therapy for treatment of invasive mucormycosis.